Psoriatic plaque as a tumor suppressor model: identification of cellular and inflammatory pathways leading to cancer prevention.

Project
Psoriatic plaque as a tumor suppressor model: identification of cellular and inflammatory pathways leading to cancer prevention.

Academic Signature

Il servizio di classificazione ACADEMIC SIGNATURE è IN BETA TESTING e i risultati potrebbero non essere corretti

Academic Signature (2)

Overview

Contributors

GUERRINI LUISA FRANCESCA ISOTTA   Scientific Manager  

Departments involved

Dipartimento di Bioscienze   Principale  

Type

PRIN2022 - PRIN bando 2022

Funder

MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
External Organization Funding Organization

Date/time interval

October 18, 2023 - February 28, 2026

Project duration

28 months

Publications

Outputs

Molecular mechanisms of thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target gene 
JOURNAL OF MOLECULAR MEDICINE
SPRINGER NATURE
2024
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"